CTMX Stock Summary and Trading Ideas (Cytomx Therapeutics | NASDAQ:CTMX)

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

What symbol and exchange does Cytomx Therapeutics shares trade?

Cytomx Therapeutics trades on the NASDAQ stock market under the symbol CTMX.

What is Cytomx Therapeutics stock price doing today?

As of January 9, 2026, CTMX stock price climbed to $4.35 with 1,926,414 million shares trading.

What is Cytomx Therapeutics's Beta?

CTMX has a beta of 2.98, meaning it tends to be more sensitive to market movements. CTMX has a correlation of 0.22 to the broad based SPY ETF.

How much is Cytomx Therapeutics worth?

CTMX has a market cap of $737.04 million. This is considered a Small Cap stock.

How much money does Cytomx Therapeutics make?

Last quarter Cytomx Therapeutics reported $6 million in Revenue and -$.09 earnings per share. This fell short of revenue expectation by $-6 million and missed earnings estimates by -$.05.

What is the highest and lowest price Cytomx Therapeutics traded in the last 3 year period?

In the last 3 years, CTMX traded as high as $5.85 and as low as $.40.

What are the top ETFs holding Cytomx Therapeutics?

The top ETF exchange traded funds that CTMX belongs to (by Net Assets): XBI, VTI, VXF, IBB, FDM.

Is Cytomx Therapeutics (CTMX) a good investment?

CTMX has outperformed the market in the last year with a return of +342.6%, while the SPY ETF gained +19.0%. In the last 3 month period, CTMX beat the market returning +26.1%, while SPY returned +3.7%. However, in the most recent 2 weeks CTMX has underperformed the stock market by returning -0.9%, while SPY returned +0.5%.

What are the support and resistance levels for Cytomx Therapeutics (CTMX)?

CTMX support price is $4.08 and resistance is $4.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTMX shares will trade within this expected range on the day.